Business · 21/09/2005Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 13 New Drug Applications from High Chemical Co. and Others
Summary
The FDA has withdrawn approval of 13 new drug applications from multiple holders due to repeated failure to submit required annual reports, a requirement for maintaining application status.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →